Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort-term InvestmentsWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to $14.9 million.

  • Burning Rock Biotech's Non-Current Assets fell 64.09% to $10.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.7 million, marking a year-over-year decrease of 50.43%. This contributed to the annual value of $14.9 million for FY2024, which is 32.19% down from last year.
  • Latest data reveals that Burning Rock Biotech reported Non-Current Assets of $14.9 million as of FY2024, which was down 32.19% from $22.0 million recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's Non-Current Assets peaked at $71.8 million during FY2021, and registered a low of $14.9 million during FY2024.
  • Over the past 3 years, Burning Rock Biotech's median Non-Current Assets value was $22.0 million (recorded in 2023), while the average stood at $28.2 million.
  • In the last 5 years, Burning Rock Biotech's Non-Current Assets soared by 236.21% in 2021 and then crashed by 53.92% in 2023.
  • Over the past 5 years, Burning Rock Biotech's Non-Current Assets (MRY) stood at $21.4 million in 2020, then surged by 236.21% to $71.8 million in 2021, then plummeted by 33.64% to $47.7 million in 2022, then plummeted by 53.92% to $22.0 million in 2023, then plummeted by 32.19% to $14.9 million in 2024.
  • Its Non-Current Assets was $14.9 million in FY2024, compared to $22.0 million in FY2023 and $47.7 million in FY2022.